SuperworthRetractable Technologies profit margin RVP
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- −9.9%
- Operating margin, 12 months
- −66.9%
- Net margin on a year earlier
- +13.0 pts
- Peer median
- 6.8%
Over the twelve months to Jun 30, 2026, Retractable Technologies kept −9.9% of its revenue as net profit, with an operating margin of −66.9% and a gross margin of −1.4%.
Five years earlier its net margin was 32.1%.
The median for 3 medical instruments and supplies stocks of a similar size is 6.8%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −32.8% | −55.3% | 0.1% |
| FY2024 | −36.0% | −63.9% | −3.1% |
| FY2023 | −16.1% | −26.4% | 20.9% |
| FY2022 | 5.4% | −0.9% | 29.8% |
| FY2021 | 29.8% | 38.5% | 50.6% |
| FY2020 | 29.6% | 29.4% | 45.2% |
| FY2019 | 7.5% | 7.1% | 33.8% |
| FY2018 | −4.0% | −4.0% | 30.7% |
| FY2017 | −10.8% | −11.0% | 28.9% |
| FY2016 | −12.4% | −11.8% | 34.7% |
| FY2015 | 14.6% | −10.9% | 35.8% |
| FY2014 | −6.8% | −6.3% | 34.8% |
| FY2013 | −20.2% | −19.3% | 33.5% |
| FY2012 | −12.3% | −11.7% | 33.2% |
| FY2011 | 4.4% | −12.7% | 34.0% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −9.9% | +13.0 pts | −66.9% | |
| Q1 FY26 | −16.9% | +50.7 pts | −61.0% | |
| Q4 FY25 | −32.8% | +3.1 pts | −55.3% | |
| Q3 FY25 | −17.0% | +24.1 pts | −54.6% | |
| Q2 FY25 | −22.9% | +23.8 pts | −58.1% | |
| Q1 FY25 | −67.6% | −48.8 pts | −67.6% | |
| Q4 FY24 | −36.0% | −19.9 pts | −63.9% | |
| Q3 FY24 | −41.1% | −14.4 pts | −43.5% | |
| Q2 FY24 | −46.7% | −43.5 pts | −32.6% | |
| Q1 FY24 | −18.8% | −16.3 pts | −29.2% | |
| Q4 FY23 | −16.1% | −21.4 pts | −26.4% | |
| Q3 FY23 | −26.7% | −48.1 pts | −39.4% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Retractable Technologies' size, closest first, today.
| Company | Profit margin |
|---|---|
| RVPRetractable Technologies | −9.9% |
| NEPHNephros | 8.4% |
| APTAlpha Pro Tech | 6.8% |
| KEQUKewaunee Scientific | 3.0% |
| Peer median | 6.8% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Retractable Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.